Market Place
Sourcing Support
All News #Library
Rare Diseases
Stoke Aims To Restore Developmental Loss In Dravet Syndrome
18 Mar 2026 //
FIERCE BIOTECH
Stoke, Biogen Unveil Zorevunersen Data Syndrome for Dravet at AES
05 Dec 2025 //
PHARMIWEB
Stoke, Biogen Publish 2-Year Dravet Data
18 Nov 2025 //
BUSINESSWIRE
Stoke Therapeutics Reveals 2-Year Data On ADOA
20 Oct 2025 //
PHARMIWEB
Biogen, Stoke Present Zorevunersen Data In Dravet Syndrome
02 Sep 2025 //
PHARMAWEB
First Patient Dosed in Ph 3 Biogen, Stoke Dravet Study
11 Aug 2025 //
GLOBENEWSWIRE
Biogen, Stoke Reveal Zorevunersen Data for Dravet Syndrome
10 Jul 2025 //
GLOBENEWSWIRE
Biogen and Stoke Strike Dravet Syndrome Co-Development Deal
19 Feb 2025 //
BIOSPACE
Stoke Therapeutic Presents Data On Zorevunersen For Dravet Syndrome
06 Dec 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.